思路迪医药股份（01244）今日盘中大跌5.38%，引起市场关注。这一显著跌幅与公司最新发布的年度业绩报告密切相关。
根据思路迪医药股份发布的截至2024年12月31日止年度业绩报告，公司财务状况出现明显下滑。具体来看，公司实现收入4.46亿元，同比减少29.81%；毛利为4.09亿元，同比减少30.18%。更值得注意的是，经调整年内全面亏损总额达1.67亿元，同比减少36.75%；母公司拥有人应占亏损高达1.83亿元，同比减少65.19%。
这份业绩报告无疑给投资者带来了负面影响。收入的大幅下降和亏损的扩大表明公司在过去一年面临严峻的经营挑战。市场对这一消息反应强烈，导致股价在盘中出现大幅下跌。分析人士指出，如果思路迪医药股份无法在短期内改善其财务状况和经营表现，可能会继续面临投资者信心下降的风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.